Document Mentions (4 shared documents)

HOUSE_OVERSIGHT_024003_sub_001 - HOUSE_OVERSIGHT_024102

3 mentions1 same-page

Page ?Same page

oard certified medical oncologist and former chairman of Park Nicollet Health Services and was previously a medical director for CIGNA Health Care of Kansas City. Dr. Newcomer was a founding executive of Vivius, a consumer directed venture that allowed consumers to create their own personalized health plans.

t and XDx, while maintaining board observer status with Labcyte. Vijay was previously on the boards of Advanced Cell Diagnostics, Ilypsa (acquired by Amgen) and Relypsa (NASDAQ: RLYP). Prior to joining Sprout, Vijay spent one year as an analyst in the healthcare venture capital group at Robertson Stephen

quently split to become 2 separate companies), Durata Therapeutics (NLV-II: IPO - July, 2012, NASDAQ: DRTX), and Ilypsa (Sprout IX, exited in sale to Amgen, 6.9x multiple). e Established Private Companies: The New Leaf Team has played the role of lead investor in a large number of private investments. T

EFTA00136746

2 mentions1 same-page

Page ?Same page

dy, including more than three hundred arrests for violent crime in St. Louis. He noted that 33 of those arrests were for homicides." EFTA00136753 Kansas City Mayor Launches Law Enforcement Effort Modeled After Operation LeGend. The Kansas City (MO) Star <https://www.kansascity.com/news/local/crime/article

ing on `unsustainable drug prices' concludes — Hybrid hearing on `Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM * Tom Lantos Human

EFTA00135712

2 mentions1 same-page

Page ?Same page

initiative launched this summer that aimed to get killers off the streets. It was named for 4-year-old LeGend Taliferro, who was shot and killed in Kansas City while sleeping in June." Operation LeGend Assisting Memphis Police With Several Child Murders. WHBQ-TV Memphis, TN (9/30, Coy, 23K) reports, "Memp

ing on 'unsustainable drug prices' concludes - Hybrid hearing on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human